نتایج جستجو برای: familial breast cancer

تعداد نتایج: 1032090  

Journal: :Wiener medizinische Wochenschrift 1996
C Vutuc G Haidinger

Breast cancer is the leading cause of cancer in females in Austria (25% of all newly diagnosed cancer cases). So far no comprehensive theory about etiology exists. Risk factors generally considered to be established are: demographic, reproductive and hormonal factors, diet, benign breast disease, familial aggregation and genetics. Most of the risk factors cannot be affected by primary preventio...

Journal: :The Ulster Medical Journal 2003
R A J Spence

This text book is a timely publication and it gives a splendid overview of the genetics and management of familial breast and ovarian cancer. The book is edited by Professor Morrison and his colleagues and they have drawn together a national and an international list ofcontributors well respected in their fields. The book begins with a series of book chapters on molecular biology of these tumours.

2015
Ella R. Thompson Kylie L. Gorringe Simone M. Rowley Na Li Simone McInerny Michelle W. Wong-Brown Lisa Devereux Jason Li Ian G. Campbell Lisa Devereux John Hopper Vicki Pridmore Anne Kavanagh Gillian Mitchell Bruce Mann Stephen Fox Alison H. Trainer Gillian Mitchell Rodney J. Scott Paul A. James Ian G. Campbell

The breast cancer predisposition gene, BRCA2, has a large number of genetic variants of unknown effect. The variant rs11571833, an A > T transversion in the final exon of the gene that leads to the creation of a stop codon 93 amino acids early (K3326*), is reported as a neutral polymorphism but there is some evidence to suggest an association with an increased risk of breast cancer. We assessed...

Journal: :Journal of medical genetics 2002
N Kazerouni C Schairer H B Friedman J V Lacey M H Greene

Despite recent declines in its incidence, endometrial cancer remains the most common cancer of the female reproductive tract in the United States and in the western world. Well established risk factors include exposure to unopposed oestrogen, older age, nulliparity, obesity, and smoking. There are inconsistent reports on the association between endometrial cancer risk and family history of any ...

Journal: :Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009
Shauna N Vasilatos Gloria Broadwater William T Barry Joseph C Baker Siya Lem Eric C Dietze Gregory R Bean Andrew D Bryson Patrick G Pilie Vanessa Goldenberg David Skaar Carolyn Paisie Alejandro Torres-Hernandez Tracey L Grant Lee G Wilke Catherine Ibarra-Drendall Julie H Ostrander Nicholas C D'Amato Carola Zalles Randy Jirtle Valerie M Weaver Victoria L Seewaldt

BACKGROUND Only 5% of all breast cancers are the result of BRCA1/2 mutations. Methylation silencing of tumor suppressor genes is well described in sporadic breast cancer; however, its role in familial breast cancer is not known. METHODS CpG island promoter methylation was tested in the initial random periareolar fine-needle aspiration sample from 109 asymptomatic women at high risk for breast...

2012
Felipe Vaca-Paniagua Rosa María Alvarez-Gomez Verónica Fragoso-Ontiveros Silvia Vidal-Millan Luis Alonso Herrera David Cantú Enrique Bargallo-Rocha Alejandro Mohar César López-Camarillo Carlos Pérez-Plasencia

Hereditary breast cancer comprises 10% of all breast cancers. The most prevalent genes causing this pathology are BRCA1 and BRCA2 (breast cancer early onset 1 and 2), which also predispose to other cancers. Despite the outstanding relevance of genetic screening of BRCA deleterious variants in patients with a history of familial cancer, this practice is not common in Latin American public instit...

2013
Francisco Javier Gracia-Aznarez Victoria Fernandez Guillermo Pita Paolo Peterlongo Orlando Dominguez Miguel de la Hoya Mercedes Duran Ana Osorio Leticia Moreno Anna Gonzalez-Neira Juan Manuel Rosa-Rosa Olga Sinilnikova Sylvie Mazoyer John Hopper Conchi Lazaro Melissa Southey Fabrice Odefrey Siranoush Manoukian Irene Catucci Trinidad Caldes Henry T. Lynch Florentine S. M. Hilbers Christi J. van Asperen Hans F. A. Vasen David Goldgar Paolo Radice Peter Devilee Javier Benitez

The identification of the two most prevalent susceptibility genes in breast cancer, BRCA1 and BRCA2, was the beginning of a sustained effort to uncover new genes explaining the missing heritability in this disease. Today, additional high, moderate and low penetrance genes have been identified in breast cancer, such as P53, PTEN, STK11, PALB2 or ATM, globally accounting for around 35 percent of ...

Journal: :Carcinogenesis 2008
Irene Catucci Paolo Verderio Sara Pizzamiglio Siranoush Manoukian Bernard Peissel Monica Barile Laura Tizzoni Loris Bernard Fernando Ravagnani Laura Galastri Marco A Pierotti Paolo Radice Paolo Peterlongo

Ultraconserved elements (UCEs) are segments of >200 bp length showing absolute sequence identity between orthologous regions of human, rat and mouse genomes. The selection factors acting on these UCEs are still unknown. Recent studies have shown that UCEs function as long-range enhancers of flanking genes or are involved in splicing when overlapping with exons. The depletion of UCEs among copy ...

2013
JOSEFA SALGADO MARTA SANTISTEBAN CRISTINA GUTIÉRREZ CARMEN GIL MAITANE ROBLES ADRIANA VIEDMA ANA PATIÑO-GARCÍA

Germline mutations in the human breast cancer genes BRCA1 and BRCA2 account for a substantial proportion of familial, early-onset breast and ovarian cancers. The present study reports a novel disease-causing BRCA1 mutation, nucleotide 3020insCT/c.2901insCT, in a 55-year-old Spanish female with breast and ovarian cancer. This frameshift mutation creates a premature stop codon at amino acid 1000,...

Journal: :Clinical cancer research : an official journal of the American Association for Cancer Research 2005
Lorenzo Melchor Sara Alvarez Emiliano Honrado José Palacios Alicia Barroso Orland Díez Ana Osorio Javier Benítez

PURPOSE AND METHODS High-level DNA amplifications are recurrently found in breast cancer, and some of them are associated with poor patient prognosis. To determine their frequency and co-occurrence in familial breast cancer, we have analyzed 80 tumors previously characterized for BRCA1 and BRCA2 germ-line mutations (26 BRCA1, 18 BRCA2, and 36 non-BRCA1/2) using high-resolution comparative genom...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید